This is a preview of subscription content, log in via an institution to check access.
Reference
Li X, et al. Budget impact and cost-effectiveness analyses of direct-acting antivirals for chronic hepatitis C virus infection in Hong Kong. European Journal of Clinical Microbiology and Infectious Diseases : 17 May 2017. Available from: URL: http://doi.org/10.1007/s10096-017-2995-7
Rights and permissions
About this article
Cite this article
DAAs value for money in chronic HCV infection in Hong Kong. PharmacoEcon Outcomes News 779, 15 (2017). https://doi.org/10.1007/s40274-017-4030-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4030-8